Vasonatrin Peptide (1-27) ,CAS:141676-35-9
Vasonatrin Peptide (1-27)
Product description
Chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) that possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions associated with neither ANP nor CNP. Its sequence contains the 22 amino acids of CNP plus the 5 C-terminal amino acids of ANP.
Appearance | N/A |
---|---|
Molecular weight | N/A |
Purity | >90% |
Solubility | N/A |
Cas | 141676-35-9 |
Sequence | H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (trifluoroacetate salt) (Cys6 and 22 bridge) |
One letter sequence | GLSKGCFGLKLDRIGSMSGLGCNSFRY (Cys6 and 22 bridge) |
Molecular formula | C124H198N36O36S3 |
Storage | -20℃,protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |
Document
Related Product